| Diagnosis | Acute leukemia, 189 (44); MDS, 41 (10); lymphoma, 102 (25); other, 90 (21) |
| Donor type | Sibling, 232 (55); unrelated, 190 (45) |
| HLA 8/8 identity | 357 (85) |
| Stem-cell source | Peripheral blood, 333 (80); bone marrow, 63 (15); umbilical cord, 22 (5) |
| Conditioning | Myeloablative, 208 (49); reduced intensity, 214 (51) |
| Total body irradiation | 188 (45) |
| GvHD prophylaxis | Cyclosporine + MTX, 191 (46); cyclosporine + mycophenolate, 183 (44); other, 41 (10) |
| Risk for CMV reactivation | Low, 158 (41); intermediate, 127 (33); high, 102 (26) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.